BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

DNAlite Therapeutics

DNAlite Therapeutics logo

Founded
2016
Geography
United States of America based
Funding
$1.500 M

DNAlite Therapeutics committed to bringing the next-generation of drugs to organs protected by mucus barriers. Diseases such as FAP, colorectal cancer, and Crohn's disease are currently treated with complete or partial removal of the colon and/or rectum. Our aim is to prevent, rather than manage the progression of these diseases.

Technologies

Gene Therapy Startups  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet